Evidence map›Paper›PMID 38137808›Full record

ArticleJournal of clinical medicine2023

Survival and Results after Resection and Reconstruction with Megaprosthesis at the Hip in Octogenarians.

Guido Scoccianti, Matteo Innocenti, Roberto Scanferla, Federico Scolari, Francesco Muratori, Andrea Ungar, Carlo Rostagno, Domenico Andrea Campanacci

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Guido ScocciantiDepartment of Orthopaedic Oncology, Careggi University Hospital, 50134 Firenze, Italy.ORCID 0000-0003-0637-6896
Matteo InnocentiOrthopaedic Clinic, Careggi University Hospital, 50134 Firenze, Italy.
Roberto ScanferlaDepartment of Orthopaedic Oncology, Careggi University Hospital, 50134 Firenze, Italy.ORCID 0000-0002-4271-8278
Federico ScolariDepartment of Health Sciences, University of Florence, 50121 Florence, Italy.ORCID 0000-0001-5490-672X
Francesco MuratoriDepartment of Orthopaedic Oncology, Careggi University Hospital, 50134 Firenze, Italy.
Andrea UngarDepartment of Internal and Geriatric Medicine, Careggi University Hospital, 50134 Firenze, Italy.
Carlo RostagnoDepartment of Internal and Postoperative Medicine, Careggi University Hospital, 50134 Firenze, Italy.ORCID 0000-0002-7764-8919
Domenico Andrea CampanacciDepartment of Orthopaedic Oncology, Careggi University Hospital, 50134 Firenze, Italy.ORCID 0000-0002-3912-3943
Azienda Ospedaliero-Universitaria Careggi · ITUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Few data are available about results after procedures of resection and megaprosthesis at the hip in very elderly patients. The aim of our study was to ascertain survival and complications in patients aged 80 or older undergoing these major orthopedic procedures. A consecutive series of 27 procedures in 26 patients aged 80-93 years was evaluated. In total, 15 procedures were performed due to oncological diseases, 6 were performed following joint arthroplasty failures or periprosthetic fractures, and 6 were performed after trauma or trauma sequelae. Survival of the patients ranged from 0 to 122 months. Overall survival was 56% at 3 years, 24% at 5 years, and 16% at 8 years. An early postoperative death during the first 3 months occurred in five patients (18.5%). The only preoperative parameter negatively affecting survival was preoperative hemoglobin lower than 11 g/dL. Local complications were similar to reported rates in all-age patients' series. In our experience, resection and megaprosthetic reconstruction can also be a valid choice in very elderly patients, with 56% of patients living more than two years from surgery and 24% more than five. Nevertheless, early postoperative deaths are frequent. A multidisciplinary evaluation of frailty of the patient must be accomplished, and patients and relatives must be informed about the risks of the procedure.

Indexed as

bone tumorsgeriatric surgerymegaprosthesesvery elder

Identifiers

PMID38137808
PMCPMC10743573
OpenAlexW4389914652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.